Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.

Clinical trial NCT00401830 · COMPLETED

Trial details

NCT number: NCT00401830
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibromyalgia Syndrome

Start date: 2006-10-01
Primary completion: 2008-02-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.